NOBIN-based phosphoramidite and phosphorodiamidite ligands and their use in asymmetric nickel-catalysed hydrovinylation†
Received
19th September 2012
, Accepted 30th October 2012
First published on 1st November 2012
Abstract
Phosphoramidite and P-stereogenic phosphorodiamidite ligands derived from (Sa)-2-phenylamino-2′-hydroxy-1,1′-binaphthyl (N-Ph-NOBIN) and bis(1-phenyl-ethyl)amine were synthesised, fully characterised, and the absolute configuration of the stereogenic phosphorus atoms was assigned. The phosphoramidite ligand L2 features three non-bridged substituents at phosphorus comprising the bis(1-phenylethyl)amine and two NOBIN moieties. The NOBIN units are bound to the phosphorus through the oxygen atoms with two pendant nitrogen atoms. In the Ni-catalysed hydrovinylation of styrene no conversion was observed with the phosphorodiamidites, while the phosphoramidite ligands led to active catalysts with a marked co-operative effect on selectivities. Whereas the racemic product was obtained with the (Sa,Sa,SC,SC) diastereomer, the (Sa,Sa,RC,RC) diastereomer proved to be one of the best ligands for this reaction, leading to almost perfect selectivity and ees of up to 91%.
Introduction
Chiral phosphorus(III) compounds in which the donor atom is surrounded by heteroatoms are finding increasing application as ligands for transition metal catalysed reactions.1 Their synthesis is modular and suitable for automation allowing for the creation of ligand libraries to rapidly assess the optimum structure for a given application.2 In particular, BINOL-based (BINOL = 1,1′-binaphthyl-2,2′-diol) phosphoramidites are excellent chiral auxiliaries for a variety of asymmetric metal-catalysed reactions when used as monodentate ligands3 as well as in combination with a second donor group within the same molecule4 or with a second ligand.5 More recently, several groups synthesised phosphorous triamides based on variously substituted 2,2′-diamino-1,1′-binaphthyl backbones6–8 and applied them in catalysis, albeit without reaching the efficiency level of the related phosphoramidites. A small number of monodentate phosphorodiamidite (diamido phosphite) ligands have also been synthesised, either from diamines and an alcohol or amino alcohols and amines.1 Their use in catalysis is far less investigated.9 In all cases, the bidentate units bind to phosphorus in a “chelating-type” fashion, resulting in the cyclic structure of type A (Fig. 1).
Despite the close similarity of the atropoisomeric amino-alcohol NOBIN (NOBIN = 2′-amino-1,1′-binaphthyl-2-ol)10 to BINOL, no corresponding phosphorodiamidite ligands have been reported yet.11 Intrigued by this structural variation, we set to synthesise phosphorodiamidite ligands from the NOBIN moiety and the bis(1-phenylethyl)amine, a very successful chiral synthon for phosphoramidite ligands.12,13
We describe here the synthesis of P-stereogenic phosphorodiamidite derived from (Sa)-2′-(phenylamino)-1,1′-binaphthyl-2-ol and both enantiomers of bis(1-phenylethyl)amine. In addition to the expected phosphorodiamidite of structure A, the non-cyclic phosphoramidite structure B (Fig. 1) could be obtained in excellent yields and proved the preferred arrangement in asymmetric hydrovinylation.
Results and discussion
The synthesis of the phosphorodiamidites of type A was carried out using a protocol established for the phosphoramidites14 or phosphorous triamide7,8 congeners (Scheme 1). Adding an equimolar amount of (Sa)-N-Ph-NOBIN to enantiopure 1,1-dichloro-N,N-bis(1-phenylethyl)phosphinamine (SC,SC)-1 at 0 °C in CH2Cl2 in the presence of NEt3 resulted in the formation of two P-containing products, which could be separated through column chromatography and isolated in pure form (vide infra). The major product (45% yield), displaying in the 31P{1H}-NMR-spectrum a singlet at δ = 142.72 ppm, corresponds to the anticipated phosphorodiamidite (Sa,SC,SC,RP)-L1 and was obtained as a single diastereomer. A similar outcome was observed by the reaction of (Sa)-N-Ph-NOBIN with (RC,RC)-1. Again, a single phosphorodiamidite diastereomer (Sa,RC,RC,RP)-L1 was isolated in 35% yield (31P{1H}-NMR: singlet, δ = 135.00 ppm). These results indicate that the formation of one diastereomer of type A with NOBIN is kinetically and/or thermodynamically highly preferred over the other.15
The assignment of the absolute configuration of the stereogenic phosphorus atom16 was accomplished by computational methods and corroborated by NMR spectroscopy. The conformational minima for both diastereomeric pairs were calculated via conformational searches at the PM3 level followed by geometry optimisation through DFT calculation (see ESI†). The calculation showed that for both phosphorodiamidites (Sa,SC,SC)-L1 and (Sa,RC,RC)-L1 the R configuration at the phosphorus is strongly favoured with a ΔG of 8.7 and 5.2 kcal mol−1 for the pairs (Sa,SC,SC,RP)–(Sa,SC,SC,SP) and (Sa,RC,RC,RP)–(Sa,RC,RC,SP), respectively. These findings were confirmed in solution by 2D NOE experiments, where predicted interactions specific for RP-diastereomers were actually found (see ESI†).
The minor products isolated in 12–13% yield from the reactions described above showed in the 31P{1H}-NMR-spectra a singlet at δ = 141.17 and 141.37 ppm for the compound obtained from (Sa)-N-Ph-NOBIN with (SC,SC)-1 and (RC,RC)-1, respectively. 1H and 13C NMR spectroscopy as well as mass analysis revealed these compounds as phosphoramidites of type B comprising a bis(1-phenyl-ethyl)amine and two (Sa)-N-Ph-NOBIN moieties, which are bound to the phosphorus through the oxygen atoms. The latter connectivity could be unequivocally confirmed on the basis of 13C NMR: the quaternary carbons next to the oxygen atoms appear as doublets at δ = 150.59 (J13C–31P = 6.3 Hz) and 150.43 (J13C–31P = 7.6 Hz) ppm for (Sa,Sa,SC,SC)-L2 and at δ = 150.84 (J13C–31P = 8.6 Hz) and 150.30 (J13C–31P = 1.8 Hz) ppm for (Sa,Sa,RC,RC)-L2, respectively, as the most downfield signals. In contrast, in both diastereomers the quaternary carbon next to the nitrogen atoms does not show any phosphorus-coupling.
Based on this unexpected observation, the reaction conditions were adjusted in order to favour the formation of type B structures. Thus, the synthesis was carried out using a (Sa)-N-Ph-NOBIN/1 molar ratio of 2
:
1, the addition sequence inverted (i.e. the PCl2-compound 1 was added to NOBIN), and the concentration increased by a factor of 10 to facilitate the inter- over the intra-molecular addition (Scheme 2). Indeed, phosphoramidites (Sa,Sa,SC,SC)- and (Sa,Sa,RC,RC)-L2 formed as the only P-containing species and could be isolated in 69% and 70% yields, respectively.
 |
| Scheme 2 Phosphoramidite synthesis. | |
The diastereomeric pairs of novel ligand structures L1 and L2 were applied in the Ni-catalysed hydrovinylation of styrene (Scheme 3),17 where BINOL-based phosphoramidites are the benchmark ligands.18
Both (Sa,RC,RC,RP)-L1 and (Sa,SC,SC,RP)-L1 did not form an active Ni-catalyst (Table 1, entries 1 and 2). This result is surprising as the structure of the phosphorodiamidites L1 lies “in-between” that of the Feringa phosphoramidite and that of the phosphorous triamides based on the 2,2′-diamino-1,1′-binaphthyl backbone, which led to high conversions and enantioselectivities of 91% and 40% ee, respectively, under similar reaction conditions.8,18a
Entry |
Ligand |
2/[Ni] |
T (°C) |
t (h) |
Conversion (%) |
Selectivitya (%) |
ee (%) |
3
|
4
|
Olig. |
Selectivity refers to products of styrene.19
|
1 |
(Sa,SC,SC,RP)-L1 |
500 |
20 |
1 |
4 |
— |
— |
— |
— |
2 |
(Sa,RC,RC,RP)-L1 |
500 |
20 |
1 |
4 |
— |
— |
— |
— |
3 |
(Sa,Sa,SC,SC)-L2 |
500 |
20 |
1 |
92 |
66 |
2 |
32 |
rac |
4 |
(Sa,Sa,RC,RC)-L2 |
500 |
20 |
1 |
>99 |
34 |
11 |
54 |
74(S) |
5 |
(Sa,Sa,RC,RC)-L2 |
200 |
−20 |
2.5 |
>99 |
85 |
2 |
13 |
88(S) |
6 |
(Sa,Sa,RC,RC)-L2 |
200 |
−30 |
2.5 |
96 |
99 |
— |
1 |
91(S) |
Most intriguingly, the use of the phosphoramidite (Sa,Sa,SC,SC)-L2 resulted in an active but unselective hydrovinylation catalyst and the target chiral product 3-phenyl-but-1-ene 3 was obtained as a racemic mixture (entry 3). The other diastereomer (Sa,Sa,RC,RC)-L2 was more active as judged from the considerable amounts of products from the consecutive isomerisation and oligomerisation reactions (entry 4). More importantly, product 3 was obtained with an enantioselectivity of 74% (S) ee. Lowering the reaction temperature to −20 °C, both selectivity and ee could be improved to 85% and 88%, respectively (entry 5). Finally, carrying out the hydrovinylation at −30 °C (entry 6), the consecutive reactions could be suppressed and 3-phenyl-but-1-ene was obtained with almost perfect selectivity19 and an ee of 91% (S). This enantioselectivity value is at the same level as that achieved with benchmark catalytic systems under comparable conditions, while the catalyst activity (TOFav of 80 h−1) is circa one order of magnitude lower. Noticeably, the new catalytic system allowed high selectivity towards 3 also at very high styrene conversion (entry 6) indicating that it is less prone to promote the isomerisation and other consecutive reactions in comparison to BINOL-based phosphoramidites.18a
Conclusions
By careful choice of the conditions, the reaction of 1,1-dichloro-N,N-bis(1-phenylethyl)phosphinamine 1 with (Sa)-N-Ph-NOBIN can be steered toward the selective formation of P-stereogenic phosphorodiamidite L1 with a chelating NOBIN moiety or phosphoramidite L2 with three non-bridged substituents (Fig. 2).
All chiral phosphoramidites successfully applied in catalysis today are based on a diol and a monoamine,3,20 and the presence of a cyclic unit is believed to ensure high stability as a necessity to impart a definite stereo-arrangement to the resulting ligand.3 In this respect, (Sa,Sa,RC,RC)-L2, composed of two (amino)alcohol moieties and a monoamine, is unique and is the first phosphoramidite of this type leading to a highly enantioselective catalytic transformation. The striking difference in the enantioselectivity obtained with two diastereomers of L2 shows once again the importance of cooperative effects between the various chiral elements within the ligand structure.21 An intervention of the free NH functionalities during the catalytic cycle cannot be excluded at this stage.
Experimental section
General remarks
All reactions and manipulations were performed using standard Schlenk techniques or in a glovebox under an argon atmosphere. 1H-, 13C- and 31P-NMR spectra were recorded on a Bruker AV 600 (600, 150 and 243 MHz, respectively). Chemical shifts were referenced to residual solvent peaks (1H-NMR, 13C-NMR) or H3PO4 85% as external standard (31P-NMR). Mass spectra were recorded on a Finnigan MAT 95 (HRMS-ESI). Optical rotations were measured on a Jasco P-1020 polarimeter. The concentrations used for measuring specific rotations are given as g per 100 mL. CH2Cl2 and n-pentane were dried over alumina and molecular sieves with a solvent purification system from Innovative Technology. NEt3 was freshly distilled from KOH. CDCl3 was degassed through freeze–pump–thaw cycles and stored above molecular sieves. The following substances have been synthesised according to literature procedures: (Sa)-NOBIN,22 (Sa)-N-Ph-NOBIN,23 (SC,SC)-1 and (RC,RC)-1,24 NaBArF,25 [Ni(allyl)Br]2.26 Ethylene (purity 2.5) was purchased from Westfalen AG. Silica gel (SiO2 60, 0.04–0.063 mm, 230–400 mesh) was purchased from Roth. All other chemicals were purchased from Sigma-Aldrich or Alfa Aesar and used as received.
(11bS)-5-Phenyl-N,N-bis((S)-1-phenylethyl)dinaphtho[2,1-d:1′,2′-f][1,3,2]oxazaphosphepin-4(5H)-amine, (Sa,SC,SC,RP)-L1.
To a solution of (SC,SC)-1 (229.7 mg, 0.704 mmol) in CH2Cl2 (70 mL) at 0 °C was added NEt3 (10 eq., 0.98 mL, 7.04 mmol) via a syringe and then dropwise a solution of (Sa)-N-Ph-NOBIN (254.5 mg, 0.704 mmol) in the same solvent (30 mL). The reaction mixture was stirred at rt for 16 h and then the volatiles were removed under reduced pressure. The resulting yellowish solid was purified via flash column chromatography (SiO2, CH2Cl2
:
n-pentane = 2
:
5; (Sa,SC,SC,RP)-L1: Rf = 0.79, (Sa,Sa,SC,SC)-L2: Rf = 0.61). Yield: (Sa,SC,SC,RP)-L1 = 194 mg (45%); (Sa,Sa,SC,SC)-L2 = 83 mg (12%).
1H-NMR (600 MHz, CDCl3): δ = 8.04 (d, 1H, J = 8.8 Hz, Ar), 7.97 (d, 1H, J = 8.2 Hz, Ar), 7.90 (d, 1H, J = 7.9 Hz, Ar), 7.81 (d, 1H, J = 8.8 Hz, Ar), 7.68 (d, 1H, J = 8.8 Hz, Ar), 7.54 (d, 1H, J = 8.8 Hz, Ar), 7.51 (m, 1H, Ar), 7.48–7.42 (m, 3H, Ar), 7.39–7.31 (m, 8H, Ar), 7.28–7.22 (m, 4H, Ar), 6.85–6.76 (m, 3H, Ar), 6.22 (d, 2H, J = 7.9 Hz, Ar), 4.54 (m, 2H, CHCH3), 1.84 (d, 6H, J = 7.0 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 150.60 (Cq), 148.20 (d, J = 26.2 Hz, Cq), 143.10 (d, J = 1.4 Hz, 2Cq), 141.84 (d, J = 5.4 Hz, Cq), 133.12 (d, J = 2.4 Hz, Cq), 132.83 (Cq), 131.83 (Cq), 131.32 (Cq), 130.37 (CH), 129.88 (Cq), 129.59 (CH), 128.92 (2CH), 128.90 (2CH), 128.60 (d, J = 1.4 Hz, 2CH), 128.51 (CH), 128.11 (2CH), 128.05 (CH), 128.03 (4CH), 127.14 (2CH), 126.55 (CH), 126.21 (CH), 126.06 (CH), 125.84 (d, J = 5.5 Hz, Cq), 125.45 (CH), 124.59 (CH), 122.52 (d, J = 2.3 Hz, CH), 121.42 (CH), 121.07 (d, J = 12.7 Hz, 2CH), 54.21 (CHCH3), 54.14 (CHCH3), 21.85 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 142.72. HRMS (ESI): m/z = calcd for C68H54N3O2P: 614.24815; found: 614.24627; [α]20D = −258° (c = 0.1, CH2Cl2).
(11bS)-5-Phenyl-N,N-bis((R)-1-phenylethyl)dinaphtho[2,1-d:1′,2′-f][1,3,2]oxazaphosphepin-4(5H)-amine (Sa,RC,RC,RP)-L1.
The same procedure as above. (RC,RC)-1 was used instead of (SC,SC)-1. Purification via flash column chromatography (SiO2, CH2Cl2
:
n-pentane = 2
:
5; (Sa,RC,RC,RP)-L1: Rf = 0.75, (Sa,Sa,RC,RC)-L2: Rf = 0.64). Yield: (Sa,RC,RC,RP)-L1 = 151 mg (35%); (Sa,Sa,RC,RC)-L2 = 90 mg (13%).
1H-NMR (600 MHz, CDCl3): δ = 7.96–7.93 (m, 3H, Ar), 7.92 (d, 1H, J = 8.1 Hz, Ar), 7.62 (d, 1H, J = 8.8 Hz, Ar), 7.51–7.44 (m, 4H, Ar), 7.35–7.28 (m, 3H, Ar), 7.20–7.12 (m, 12H, Ar), 7.08 (d, 2H, J = 8.1 Hz, Ar), 6.94 (7, 1H, J = 7.3 Hz, Ar), 4.60 (m, 2H, CHCH3), 1.93 (d, 6H, J = 7.0 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 149.89 (Cq), 148.44 (d, J = 26.0 Hz, Cq), 142.73 (b, 2Cq), 141.62 (d, J = 4.2 Hz, Cq), 132.93 (d, J = 2.2 Hz, Cq), 132.74 (Cq), 131.85 (Cq), 131.22 (d, J = 1.2 Hz, Cq), 130.32 (Cq), 130.15 (CH), 129.36 (CH), 128.76 (d, J = 1.3 Hz, 2CH), 128.47 (CH), 128.24 (4CH), 128.05 (CH), 127.97 (CH), 127.76 (CH), 127.67 (4CH), 126.58 (2CH), 126.37 (CH), 126.08 (CH), 126.03 (CH), 125.77 (d, J = 5.5 Hz, Cq), 125.50 (CH), 124.45 (CH), 122.20 (d, J = 2.3 Hz, CH), 121.78 (CH), 121.18 (d, J = 13.2 Hz, 2CH), 54.12 (CHCH3), 54.05 (CHCH3), 22.15 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 135.00. HRMS (ESI): m/z = calcd for C68H54N3O2P: 614.24815; found: 614.24792; [α]20D = 579° (c = 0.1, CH2Cl2).
(1′S,1′′S)-2′,2′′-((bis((S)-1-Phenylethyl)amino)phosphinediyl)bis(phenylazanediyl)di-1,1′-bibenzobenzen-2-ol, (Sa,Sa,SC,SC)-L2.
To a solution of (Sa)-N-Ph-NOBIN (2 eq., 211.9 mg, 0.584 mmol) in CH2Cl2 (5 mL) at 0 °C was added NEt3 (20 eq., 0.81 mL, 5.84 mmol) via a syringe and then dropwise a solution of (SC,SC)-1 (1 eq., 95.3 mg, 0.292 mmol) in CH2Cl2 (10 mL). The reaction mixture was stirred at rt for 5 h and then the volatiles were removed under reduced pressure. The resulting yellowish solid was purified via flash column chromatography (SiO2 60, CH2Cl2
:
n-pentane = 2
:
5; (Sa,Sa,SC,SC)-L2: Rf = 0.61). Yield = 198 mg (69%).
1H-NMR (600 MHz, CDCl3): δ = 7.99 (d, 1H, J = 8.0 Hz, Ar), 7.93 (d, 1H, J = 9.1 Hz, Ar), 7.90 (d, 1H, J = 8.9 Hz, Ar), 7.89 (d, 1H, J = 7.9 Hz, Ar), 7.86 (d, 1H, J = 8.3 Hz, Ar), 7.81 (d, 1H, J = 9.0 Hz, Ar), 7.71 (d, 1H, J = 9.0 Hz, Ar), 7.69 (d, 1H, J = 8.3 Hz, Ar), 7.49 (m, 1H, Ar), 7.44 (m, 1H, Ar), 7.38–7.29 (m, 7H, Ar), 7.27–7.23 (m, 5H, Ar), 7.22–7.17 (m, 2H, Ar), 7.10–7.05 (m, 7H, Ar), 7.03 (d, 1H, J = 8.5 Hz, Ar), 6.98 (t, 1H, J = 7.4 Hz, Ar), 6.92 (t, 2H, J = 7.9 Hz, Ar), 6.72 (t, 1H, J = 7.4 Hz, Ar), 6.67 (d, 2H, J = 7.7 Hz, Ar), 6.65–6.59 (m, 4H, Ar), 6.48 (d, 1H, J = 8.9 Hz, Ar), 6.17 (d, 1H, J = 9.0 Hz, Ar), 5.61 (s, 1H, OH), 5.55 (s, 1H, OH), 4.31 (s br, 2H, CHCH3), 0.87 (d, 6H, J = 8.0 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 150.59 (d, J = 6.3 Hz, Cq), 150.43 (d, J = 7.6 Hz, Cq), 143.07 (Cq), 142.91 (Cq), 142.63 (2Cq), 139.83 (Cq), 139.61 (Cq), 134.95 (Cq), 134.82 (Cq), 134.24 (Cq), 133.61 (Cq), 130.53 (Cq), 130.08 (Cq), 129.72 (Cq), 129.54 (Cq), 129.46 (CH), 129.39 (CH), 129.32 (2CH), 128.94 (2CH), 128.90 (CH), 128.75 (CH), 128.35 (4CH), 128.29 (CH), 128.14 (2CH), 127.95 (CH), 127.77 (4CH), 126.84 (CH), 126.81 (2CH), 126.44 (2CH), 126.43 (CH), 125.81 (2CH), 125.65 (CH), 125.42 (CH), 124.48 (2CH), 123.43 (CH), 123.17 (CH), 121.67 (CH), 121.60 (d, J = 2.9 Hz, Cq), 121.02 (d, J = 2.6 Hz, Cq), 120.95 (CH), 120.56 (d, J = 11.6 Hz, CH), 119.91 (d, J = 17.5 Hz, CH), 119.54 (2CH), 119.32 (CH), 118.99 (Cq), 118.32 (2CH), 118.30 (Cq), 117.90 (CH), 51.81 (CHCH3), 51.74 (CHCH3), 20.67 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 141.17. HRMS (ESI): m/z = calcd for C68H54N3O2P: 975.39482; found: 975.39520; [α]20D = 173° (c = 0.1, CH2Cl2).
(1′S,1′′S)-2′,2′′-((bis((R)-1-Phenylethyl)amino)phosphinediyl)bis(phenylazanediyl)di-1,1′-bibenzobenzen-2-ol, (Sa,Sa,RC,RC)-L2.
The same procedure as above. (RC,RC)-1 was used instead of (SC,SC)-1. Purification via flash column chromatography (SiO2, CH2Cl2
:
n-pentane = 2:1); yield: = 199 mg (70%).
1H-NMR (600 MHz, CDCl3): δ = 7.96 (d, 1H, J = 9.0 Hz, Ar), 7.93–7.89 (m, 3H, Ar), 7.85 (d, 1H, J = 8.0 Hz, Ar), 7.80 (d, 1H, J = 8.2 Hz, Ar), 7.69 (d, 1H, J = 9.0 Hz, Ar), 7.64 (d, 1H, J = 9.0 Hz, Ar), 7.62 (d, 1H, J = 8.9 Hz, Ar), 7.48 (m, 1H, Ar), 7.48–7.42 (m, 1H, Ar), 7.39–7.35 (m, 2H, Ar), 7.32–7.25 (m, 5H, Ar), 7.25–7.18 (m, 3H, Ar), 7.17–7.07 (m, 6H, Ar), 7.02–6.97 (m, 3H, Ar), 6.91–6.87 (m, 2H, Ar), 6.84–6.78 (m, 6H, Ar), 6.67 (d, 2H, J = 7.6 Hz, Ar), 6.64 (d, 1H, J = 8.9 Hz, Ar), 6.45 (d, 1H, J = 7.6 Hz, Ar), 6.28 (d, 1H, J = 9.0 Hz, Ar), 5.39 (s, 1H, NH), 5.18 (s, 1H, NH), 4.33 (m, 2H, CHCH3), 0.95 (d, 6H, J = 7.2 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 150.84 (d, J = 8.6 Hz, Cq), 150.30 (d, J = 1.8 Hz, Cq), 142.98 (2Cq), 142.57 (Cq), 142.24 (Cq), 140.86 (Cq), 139.78 (Cq), 134.35 (Cq), 134.18 (Cq), 133.47 (Cq), 133.42 (Cq), 130.97 (Cq), 130.25 (CH), 129.97 (Cq), 129.47 (Cq), 129.38 (CH), 129.28 (Cq), 129.05 (2CH), 129.01 (CH), 128.96 (2CH), 128.82 (CH), 128.41 (4CH), 128.40 (CH), 128.08 (CH), 127.99 (CH), 127.87 (5CH), 126.96 (CH), 126.85 (CH), 126.81 (2CH), 126.53 (CH), 126.28 (CH), 125.37 (CH), 125.35 (CH), 125.10 (CH), 125.08 (CH), 124.96 (CH), 124.35 (CH), 123.14 (CH), 123.13 (CH), 122.83 (d, J = 3.5 Hz, Cq), 122.74 (d, J = 5.7 Hz, CH), 121.84 (2CH), 120.32 (2CH), 120.27 (d, J = 2.0 Hz, Cq), 120.07 (2CH), 119.50 (d, J = 20.5 Hz, CH), 117.79 (Cq), 117.64 (CH), 117.42 (CH), 117.41 (Cq), 52.25 (CHCH3), 52.17 (CHCH3), 20.84 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 141.37. HRMS (ESI): m/z = calcd for C68H54N3O2P: 975.39482; found: 975.39497 [α]20D = −110° (c = 0.1, CH2Cl2).
To a solution of [Ni(allyl)Br]2 in CH2Cl2 (1 mL, 5.4 × 10−3 M) at 0 °C was added a solution of the ligand (1 mL, 0.011 M) in the same solvent. After 15 min, NaBArF (10.6 mg, 0.012 mmol) was added as a solid and the mixture stirred at rt for 30 minutes. The mixture was then cooled down to the desired temperature (see Table 1) and the inert gas exchanged for ethylene by bubbling it through the solution for 5 s. Then, the appropriate amount of styrene (see Table 1) was added and the mixture vigorously stirred and kept under an ethylene atmosphere at ambient pressure during the reaction time. Saturated aqueous NH4Cl (4 mL) and the GC-standard ethylbenzene (equimolar amount to styrene) were added. The organic phase was separated, dried over Na2SO4, filtered through a short pad of silica and analysed by GC.
Acknowledgements
We thank H. Eschmann and J. Wurlitzer for GC measurements, Ms B. Pütz for the measurement of MS data, and Dr. M. Hölscher for DFT calculations. The research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement no. 246461.
Notes and references
-
(a)
Phosphorus(III) Ligands in Homogeneous Catalysis, Design and Synthesis, ed. P. C. J. Kamer and P. W. N. M. van Leeuwen, John Wiley & Sons, 2012 Search PubMed;
(b)
Phosphorus Ligands in Asymmetric Catalysis, ed. A. Börner, Wiley-VCH, Weinheim, 2008 Search PubMed;
(c) J. Ansell and M. Wills, Chem. Soc. Rev., 2002, 31, 259 RSC.
-
(a) A. J. Minnaard, B. L. Feringa, L. Lefort and J. G. De Vries, Acc. Chem. Res., 2007, 40, 1267 CrossRef CAS;
(b) L. Lefort, J. A. F. Boogers, J. G. de Vries and A. H. M. de Vries, Top. Catal., 2010, 53, 1081 CrossRef CAS;
(c) Z. Hua, V. C. Vassar and I. Ojima, Org. Lett., 2003, 5, 3831 CrossRef CAS;
(d) C. Monti, C. Gennari, U. Piarulli, J. G. Vries, A. H. M. de Vries and L. Lefort, Chem.–Eur. J., 2005, 11, 6701 CrossRef CAS.
- J. F. Teichert and B. L. Feringa, Angew. Chem., Int. Ed., 2010, 49, 2486 CrossRef CAS.
-
(a) G. Franciò, F. Faraone and W. Leitner, Angew. Chem., Int. Ed., 2000, 39, 1428 CrossRef CAS;
(b) M. Eggenstein, A. Thomas, J. Theuerkauf, G. Franciò and W. Leitner, Adv. Synth. Catal., 2009, 351, 725 CrossRef;
(c) F. Boeda, T. Beneyton and C. Crévisy, Mini-Rev. Org. Chem., 2008, 96 Search PubMed.
-
(a) M. T. Reetz, T. Sell, A. Meiswinkel and G. Mehler, Angew. Chem., Int. Ed., 2003, 42, 790 CrossRef CAS;
(b) J. A. F. Boogers, U. Felfer, M. Kotthaus, L. Lefort, G. Steinbauer, A. H. M. de Vries and J. G. de Vries, Org. Process Res. Dev., 2007, 11, 585 Search PubMed.
- M. T. Reetz, H. Oka and R. Goddard, Synthesis, 2003, 1809 CrossRef CAS.
- C. Monti, C. Gennari, R. M. Steele and U. Piarulli, Eur. J. Org. Chem., 2004, 3557 Search PubMed.
- K. Barta, M. Eggenstein, M. Hölscher, G. Franciò and W. Leitner, Eur. J. Org. Chem., 2009, 6198 Search PubMed.
- For notable exceptions see:
(a) A. Alexakis, S. Mutti and J. F. Normant, J. Am. Chem. Soc., 1991, 113, 6332 CrossRef CAS;
(b) V. N. Tsarev, S. E. Lyubimov, A. A. Shiryaev, S. V. Zheglov, O. G. Bondarev, V. A. Davankov, A. A. Kabro, S. K. Moiseev, V. N. Kalinin and K. N. Gavrilov, Eur. J. Org. Chem., 2004, 2214 CrossRef CAS;
(c) M. D. K. Boele, P. C. J. Kamer, M. Lutz, A. L. Spek, J. G. de Vries, P. W. N. M. van Leeuwen and G. P. F. van Strijdonck, Chem.–Eur. J., 2004, 10, 6232 CrossRef CAS;
(d) K. N. Gavrilov, S. E. Lyubimov, O. G. Bondarev, M. G. Maksimova, S. V. Zheglov, P. V. Petrovskii, V. A. Davankov and M. T. Reetz, Adv. Synth. Catal., 2007, 349, 609 CrossRef CAS;
(e) M. Kimura and Y. Uozumi, J. Org. Chem., 2006, 72, 707 Search PubMed;
(f) O. G. Bondarev and R. Goddard, Tetrahedron Lett., 2006, 47, 9013 CrossRef CAS;
(g) T. Nemoto and Y. Hamada, Tetrahedron, 2011, 67, 667 Search PubMed;
(h) E. B. Benetskiy and C. Bolm, Tetrahedron: Asymmetry, 2011, 22, 373 Search PubMed;
(i) I. Ayora, R. M. Ceder, M. Espinel, G. Muller, M. Rocamora and M. Serrano, Organometallics, 2011, 30, 115 CrossRef CAS.
- K. Ding, X. Li, B. Ji, H. Guo and M. Kitamura, Curr. Org. Synth., 2005, 2, 499 Search PubMed.
- For P,N-ligands derived from NOBIN see e.g.:
(a) X. Hu, H. Chen and X. Zhang, Angew. Chem., Int. Ed., 1999, 38, 3518 CrossRef CAS;
(b) Y. Hu, X. Liang, J. Wang, Z. Zheng and X. Hu, J. Org. Chem., 2003, 68, 4542 CrossRef CAS. For P,P′-ligands see e.g.:
(c) Y. Yan and X. Zhang, J. Am. Chem. Soc., 2006, 128, 7198 CrossRef CAS.
- B. L. Feringa, M. Pineschi, L. A. Arnold, R. Imbos and A. H. M. de Vries, Angew. Chem., Int. Ed. Engl., 1997, 36, 2620 CrossRef CAS.
-
(a) H. Zhou, W.-H. Wang, Y. Fu, J.-H. Xie, W.-J. Shi, L.-X. Wang and Q.-L. Zhou, J. Org. Chem., 2003, 68, 1582 CrossRef CAS;
(b) H. Teller, S. Flügge, R. Goddard and A. Fürstner, Angew. Chem., Int. Ed., 2010, 49, 1949 CAS.
- A. van Rooy, D. Burgers, P. C. J. Kamer and P. W. N. M. van Leeuwen, Recl. Trav. Chim. Pays-Bas, 1996, 115, 492 CAS.
- Different diastereomeric purities depending on the substitution patterns have been reported for related P-stereogenic phosphoramidites based on BINOL bearing a single substituent at the 3-position. See:
(a) M. T. Reetz, J.-A. Ma and R. Goddard, Angew. Chem., Int. Ed., 2005, 44, 412 CrossRef CAS;
(b) K. N. Gavrilov, E. B. Benetsky, V. E. Boyko, E. A. Rastorguev, V. A. Davankov, B. Schaffner and A. Börner, Chirality, 2010, 22, 844 Search PubMed;
(c) B. M. Trost, D. A. Bringley and S. M. Silverman, J. Am. Chem. Soc., 2011, 133, 7664 Search PubMed.
- The nitrogen atom in the NOBIN backbone is a potential stereogenic centre too. However, as shown by the DFT calculations (see ESI†), the nitrogen is perfectly trigonal planar (sp2 hybridisation). The same structural feature is common also for phosphoramidite ligands (ref. 3). Interestingly, upon ligand coordination a change in the geometry of the nitrogen from planar to pyramidal is observed resulting in an additional stereocenter see e.g. G. Franciò, C. G. Arena, F. Faraone, C. Graiff, M. Lanfranchi and A. Tiripicchio, Eur. J. Inorg. Chem., 1999, 1219 Search PubMed.
-
(a)
G. Franciò, W. Leitner and P. L. Alsters, Hydrovinylation and Hydroarylation of Carbon–Carbon Double Bonds, in Stereoselective Synthesis 1, ed. J. G. de Vries, Thieme, Stuttgart, 2011, p. 477 Search PubMed;
(b) T. V. RajanBabu, Synlett, 2009, 853 CrossRef CAS;
(c)
P. W. Jolly and G. Wilke, in Applied Homogeneous Catalysis with Organometallic Compounds, ed. B. Cornils and W. A. Herrman, VCH, New York, 1996, vol. 2, p. 1024 Search PubMed.
-
(a) G. Franciò, F. Faraone and W. Leitner, J. Am. Chem. Soc., 2002, 124, 736 CrossRef CAS;
(b) C. J. Diez-Holz, C. Böing, G. Franciò, M. Hölscher and W. Leitner, Eur. J. Org. Chem., 2007, 2995 CrossRef CAS;
(c) C. R. Smith and T. V. RajanBaubu, Org. Lett., 2008, 10, 1657 CrossRef CAS;
(d) N. Lassauque, G. Franciò and W. Leitner, Adv. Synth. Catal., 2009, 351, 3133 CrossRef CAS.
- Selectivity referred to products of styrene. Considerable amounts of dimers and trimers of ethylene were detected. A detailed study on the homo-oligomerisation of ethylene will be reported elsewhere.
- To the best of our knowledge, the
only phosphoramidite bearing two single alcohol moieties applied in catalysis (with poor results) was reported by Alexakis: L. Palais, I. S. Mikhel, C. Bournaud, L. Micouin, C. A. Falciola, M. Vuagnoux-d Augustin, S. Rosset, G. Bernardinelli and A. Alexakis, Angew. Chem., Int. Ed., 2007, 46, 7462 Search PubMed . Also phosphites and phosphonites with two non-bridged alcohol substituents are extremely rare: P. W. N. M. van Leeuwen, P. C. J. Kamer, C. Claver, O. Pàmies and M. Diéguez, Chem. Rev., 2011, 111, 2077 CrossRef CAS;
C. Bruneau and J.-L. Renaud, in 1b, p. 36.
- For selected examples from our group see ref. 4a and T. Hammerer, L. Weisgerber, S. Schenk, O. Stelzer, U. Englert, W. Leitner and G. Franciò, Tetrahedron: Asymmetry, 2012, 23, 53 Search PubMed.
- D. Sälinger and R. Brückner, Synlett, 2009, 109.
- S. Vyskocil, S. Jaracz, M. Smrcina, M. Sticha, V. Hanus, M. Polasek and P. Kocovsky, J. Org. Chem., 1998, 63, 7727 CrossRef CAS.
- K. Barta, M. Hölscher, G. Franciò and W. Leitner, Eur. J. Org. Chem., 2009, 4102 Search PubMed.
- N. A. Yakelis and R. G. Bergman, Organometallics, 2005, 24, 3579 CrossRef CAS.
- Procedure adapted from M. Brookhart and E. Hauptman, WO 98/22424: allyl bromide used instead of allyl chloride.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c2cy20657a |
|
This journal is © The Royal Society of Chemistry 2013 |
Click here to see how this site uses Cookies. View our privacy policy here.